Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Apr
15
2019
 A Review of Recent Whistleblower Developments: April 15th Foley & Lardner LLP
Apr
15
2019
 Athena’s Petition for Rehearing En Banc – Not All Diagnostic Claims are Equal Under s. 101 Schwegman, Lundberg & Woessner, P.A.
Apr
12
2019
 Webpage Specimens not Automatically Use in Commerce K&L Gates LLP
Apr
9
2019
 Patent Claim Preamble Lessons from Arctic Cat Inc. v. GEP Power Products Mintz
Apr
9
2019
 Did The Federal Circuit Misdiagnose Julitis Claim 1? Foley & Lardner LLP
Apr
4
2019
 Federal Circuit Addresses Obviousness of Polymorphs in Grunenthal GmbH v. Alkem Labs. Ltd., No. 2017-1153 (Fed. Cir. Mar. 28, 2019) Polsinelli PC
Apr
3
2019
 Bard Hernia Mesh MDL Moving Quickly Stark & Stark
Apr
2
2019
 Federal Circuit Finds Endo Method Of Treatment Claims Satisfy 35 USC 101 Foley & Lardner LLP
Mar
30
2019
 Ethical Duties to Former Client in Substantially Related Matters McDermott Will & Schulte LLP
Mar
29
2019
 Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101 Schwegman, Lundberg & Woessner, P.A.
Mar
29
2019
 Mootness on Appeal from PTAB McDermott Will & Schulte LLP
Mar
29
2019
 What’s "Kicking" at the ITC – the All Star Sneaker Battle Ballard Spahr LLP
Mar
29
2019
 Stick to the Pleading when Deciding Motion to Dismiss McDermott Will & Schulte LLP
Mar
29
2019
 Representations of Opposing Party's Corporate Subsidiary can Cause Disqualification McDermott Will & Schulte LLP
Mar
29
2019
 Circuits Play Jurisdictional Hot Potato with Walker Process Claim McDermott Will & Schulte LLP
Mar
29
2019
 Pilot Program for Motion to Amend Practice in PTAB Proceedings under AIA McDermott Will & Schulte LLP
Mar
29
2019
 Merely Contemplating Alternative Embodiment may Satisfy Written Description McDermott Will & Schulte LLP
Mar
28
2019
 Absent Clear Disavowal, Preferred Embodiment Does Not Limit Claim Construction McDermott Will & Schulte LLP
Mar
28
2019
 Sovereign Plaintiff Not Immune From Infringement Defenses McDermott Will & Schulte LLP
Mar
27
2019
 Ex parte Ren-Hie Xu – Are Cultured Mammalian Cells Natural Products? Schwegman, Lundberg & Woessner, P.A.
Mar
26
2019
 Federal Circuit Upholds Method Of Treatment Claims Under Vanda And Distinguishes Mayo Foley & Lardner LLP
Mar
25
2019
 Ex parte Hazokaki – Big Data Correlations in Abstract Idea “Clothing” Schwegman, Lundberg & Woessner, P.A.
Mar
21
2019
 Federal Circuit Weighs in on Patent Subject-Matter Eligibility of Dietary Supplements Sheppard, Mullin, Richter & Hampton LLP
Mar
21
2019
 Experts in the USPTO: Not Just for IPRs? Squire Patton Boggs (US) LLP
Mar
19
2019
 Precedential PTAB Panel Says Petitioners Can Join Their Own Earlier-Filed IPRs and Join New Issues in Limited Circumstance Mintz
Mar
18
2019
 Split Federal Circuit Panel Holds That Method of Medical Treatment Claims are Patent Eligible Schwegman, Lundberg & Woessner, P.A.
Mar
18
2019
 Federal Circuit Vacates Natural Product Challenge Of Dietary Supplement Claims Foley & Lardner LLP
Mar
13
2019
 Court Dismisses Biosimilar Petitioner's IPR Appeal For Lack of Standing Foley & Lardner LLP
Mar
11
2019
 New Guidance from Federal Circuit for Computer-Implemented Medical Methods Foley & Lardner LLP
Mar
8
2019
 Supreme Court Holds that a Copyright Claimant May Commence an Infringement Suit Only AFTER the Copyright Office Registers the Copyright Sheppard, Mullin, Richter & Hampton LLP
Mar
6
2019
 Federal Circuit Deals Another Blow To Asserting Sovereign Immunity Against Patent Challenges Barnes & Thornburg LLP
Mar
5
2019
 Hikma and West-Ward v. Vanda – Are Methods of Medical Treatment Patent-Eligible? Schwegman, Lundberg & Woessner, P.A.
Mar
4
2019
 USPTO Patent Eligibility Training on 2019 Revised Subject Matter Guidance Foley & Lardner LLP
Mar
3
2019
 US: Helpful Guidance from Judge Bryson Regarding Stays Pending IPR K&L Gates LLP
Feb
28
2019
 TTAB Must Consider all Relevant DuPont Factors McDermott Will & Schulte LLP
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters